Marketing oncology therapies and diagnostics, both in-market and in development, has become increasingly complex with the ever-growing number of targeted and personalised therapies.


OR:BIT (HRW’s in-house Oncology Research: Business Insights Team), not only understand the science behind the drugs but are familiar with the complex logistics of researching stakeholders, as well as integrating the market dynamics, competitive environment and emergent themes that are defining it.

HRW’s OR:BIT combines first-hand industry-side experience in marketing and market insights to offer clients expert support and relevant insights with measurable impact on product strategy.